Targeting Tumor Microenvironment by Bioreduction-Activated Nanoparticles for Light-Triggered Virotherapy-Reference-Cited by-同舟云学术

Targeting Tumor Microenvironment by Bioreduction-Activated Nanoparticles for Light-Triggered Virotherapy

Published:2018-10-02 Issue:10 Volume:12 Page:9894-9902
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Tseng S.-Ja^ORCID,Kempson Ivan M.^ORCID,Huang Kuo-Yen¹,Li Hsin-Jung,Fa Yu-Chen²,Ho Yi-Cheng³,Liao Zi-Xian²^ORCID,Yang Pan-Chyr^ORCID

Affiliation:

1. Graduate Institute of Health Industry Technology and Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33303, Taiwan

2. Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan

3. Department of BioAgricultural Science, National ChiaYi University, Chiayi City 60004, Taiwan

Funder

Academia Sinica

Ministry of Science and Technology, Taiwan

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.8b02813

Reference31 articles.

1. Tumour acidosis: from the passenger to the driver's seat

2. Multifunctional Albumin–MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response

3. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation

4. Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour

5. An injectable nanoparticle generator enhances delivery of cancer therapeutics

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-Dimensional MoS2 nanosheets as cocatalyst to augment the nanocatalytic tumor therapy;Chemical Engineering Journal;2024-09

2. Biomimetic Iron-Based Nanoparticles Remodel Immunosuppressive Tumor Microenvironment for Metabolic Immunotherapy;International Journal of Nanomedicine;2024-09

3. Clinical strategies with antibody–drug conjugates as potential modifications for virotherapy;Drug Discovery Today;2024-09

4. Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023;Frontiers in Immunology;2024-07-29

5. Utilizing adeno‐associated virus as a vector in treating genetic disorders or human cancers;IUBMB Life;2024-07-06